<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR44">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Gu</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zuo</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>An</surname>
    <given-names>Z</given-names>
   </name>
  </person-group>
  <article-title>Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014</article-title>
  <source>Vaccine</source>
  <year>2017</year>
  <volume>35</volume>
  <issue>9</issue>
  <fpage>1281</fpage>
  <lpage>1286</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.01.034</pub-id>
  <?supplied-pmid 28161421?>
  <pub-id pub-id-type="pmid">28161421</pub-id>
 </element-citation>
</ref>
